Recipient cytotoxic T lymphocyte antigen‐4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients
Authors:
- 6 September 2007
- journal article
- Published by Wiley in Liver International
- Vol. 27 (9) , 1202-1208
Abstract
Background:Single‐nucleotide polymorphisms (SNP) of two‐gene locus cytotoxic T lymphocyte antigen‐4 (CTLA‐4) +49 and CD86 +1057 were previously reported to influence the outcome of liver transplantation (LT) with respect to allograft acceptance. SNP at CTLA‐4 +49 was also suggested to be associated with the individual difference in the clearance of hepatitis B virus (HBV). However, their influence on the incidence of post‐LT HBV reinfection was not clear. With the increasing knowledge of costimulatory mechanisms on LT and host immune response, we designed this study to investigate the relationship between different alleles as well as genotypes at these two locations and HBV reinfection after LT.Methods:Genomic DNA from 167 LT recipients with HBV‐related diseases was genotyped for CTLA‐4 +49 and CD86 +1057 genomic polymorphisms using a sequence‐specific primer‐polymerase chain reaction (PCR‐SSP). HBV recurrence was diagnosed based on the serological and pathological finding of HBV DNA and HBsAg.Results:The present study indicated that the recipients with CTLA‐4 +49 GG genotype had a reduced risk (6.67%) of HBV recurrence compared with non‐CTLA‐4 +49 GG‐carrying individuals (20.7%) (relative risk 3.098) (P=0.032). The allelic frequency of CTLA‐4 +49 G was also significantly lower in patients with HBV recurrence, compared with that in patients without HBV recurrence (P=0.013, odds ratio 2.176, 95% confidence interval 1.170–4.046). However, no significant association was found between CD86 +1057 and HBV recurrence.Conclusion:Our result on CTLA‐4 +49 A/G polymorphism indicated that the CTLA‐4 +49 GG genotype was related to a reduced risk in the incidence of HBV recurrence.Keywords
This publication has 33 references indexed in Scilit:
- Histologic findings in recurrent HBVLiver Transplantation, 2006
- Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxisLiver Transplantation, 2006
- Polymorphisms at +49A/G and CT60 sites in the 3′ UTR of the CTLA‐4 gene and APECED‐related AIRE gene mutations analysis in sporadic idiopathic hypoparathyroidismInternational Journal of Immunogenetics, 2005
- CTLA-4 Gene Polymorphisms and Susceptibility to Type 1 Diabetes Mellitus: A HuGE Review and Meta-AnalysisAmerican Journal of Epidemiology, 2005
- Cytotoxic T-Lymphocyte Antigen 4 Gene and Recovery from Hepatitis B Virus InfectionJournal of Virology, 2004
- Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantationJournal of Hepatology, 2004
- Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune diseaseNature, 2003
- Association ofCTLA4Polymorphisms with Sustained Response to Interferon and Ribavirin Therapy for Chronic Hepatitis C Virus InfectionThe Journal of Infectious Diseases, 2003
- Hepatitis B: Progress in the last 15 yearsLiver Transplantation, 2002
- New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosusGenes & Immunity, 2000